Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03609580 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post-operative Urinary Retention (POUR) Following Thoracic Surgery

Study acronym: POUR
StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Mar 30, 2026 to Mar 30, 2027
    • Study site revised
    v14
  2. 2 versions Re-verified since Apr 18, 2025, no change to tracked fieldsv12-v13
  3. Primary and study completion dates: May 2, 2025 to Mar 30, 2026v11
  4. Primary and study completion dates: May 2, 2024 to May 2, 2025v10
  5. Re-verified, no change to tracked fieldsv9
Show 7 earlier versionsHide 7 earlier versions
  1. Interventions: Tamsulosin (Drug) to Tamsulosin - 1 week (Drug), Tamsulosin - 3 days (Drug)
    • Eligibility criteria shortened, about 27 words
    • Study arms: 0 to 2
    v8
  2. Study site revisedv7
  3. Eligibility criteria expanded, about 29 words
    • Site contact updated
    v6
  4. Site contact updatedv5
  5. Re-verified, no change to tracked fieldsv4
  6. Primary and study completion dates: May 2, 2020 to May 2, 2024v3
  7. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Inability to urinate a common complication that happens to many patients after a surgery, especially in men over 60 years of age who undergo surgery on their chest. Urinary retention is uncomfortable, increases anxiety, increases hospital length of stay, and leads to more procedures such as putting in a bladder catheter (Foley). This is uncomfortable, and can lead to bleeding, infection, damage to the urethra and/or bladder and bladder spasm. The goal of this study is to attempt to prevent inability to urinate by giving patients a medication called Flomax (Tamusolin) every day beginning a week before surgery. That medication relaxes the prostate. It's approved by the Food and Drug Administration (FDA) to improve urinary flow in those with enlarged prostates. It is also commonly used in patients with bladder problems due to inability to urinate who have required a Foley.
Trial Details
NCT Number NCT03609580
Lead Sponsor Hackensack Meridian Health
Conditions
(from sponsor)		 Urinary Retention
Related terms Lung Neoplasms, Urinary Retention
Enrollment 127 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov